These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9131813)

  • 1. Titration of heparinase for removal of the PCR-inhibitory effect of heparin in DNA samples.
    Taylor AC
    Mol Ecol; 1997 Apr; 6(4):383-5. PubMed ID: 9131813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction.
    Pardoe IU; Michalak TI
    J Virol Methods; 1995 Feb; 51(2-3):277-88. PubMed ID: 7738148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Treatment of Heparinized Blood Fractions to Make Them Suitable for Analysis.
    Sánchez-Fito MT; Oltra E
    Biopreserv Biobank; 2015 Aug; 13(4):287-95. PubMed ID: 26280503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparinase enables reliable quantification of circulating tumor DNA from heparinized plasma samples by droplet digital PCR.
    Sefrioui D; Beaussire L; Clatot F; Delacour J; Perdrix A; Frebourg T; Michel P; Di Fiore F; Sarafan-Vasseur N
    Clin Chim Acta; 2017 Sep; 472():75-79. PubMed ID: 28729136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.
    Ernst S; Venkataraman G; Winkler S; Godavarti R; Langer R; Cooney CL; Sasisekharan R
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):589-97. PubMed ID: 8615834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparinase: in vivo activity and immunogenicity in rabbits.
    Klein MD; Drongowski RA; Linhardt RJ; Cooney CL; Langer RS
    J Lab Clin Med; 1983 Nov; 102(5):828-37. PubMed ID: 6631173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of heparinase 1 and protamine on platelet reactivity.
    Ammar T; Fisher CF
    Anesthesiology; 1997 Jun; 86(6):1382-6. PubMed ID: 9197309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparinase I (neutralase) reversal of systemic anticoagulation.
    Michelsen LG; Kikura M; Levy JH; Lee MK; Lee KC; Zimmermann JJ; Szlam F
    Anesthesiology; 1996 Aug; 85(2):339-46. PubMed ID: 8712450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified high-throughput quantification of plasma microRNAs in heparinized patients with coronary artery disease using heparinase.
    Li S; Zhang F; Cui Y; Wu M; Lee C; Song J; Cao C; Chen H
    Biochem Biophys Res Commun; 2017 Nov; 493(1):556-561. PubMed ID: 28867189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction amplification from Plasmodium falciparum on dried blood spots.
    Long GW; Fries L; Watt GH; Hoffman SL
    Am J Trop Med Hyg; 1995 Apr; 52(4):344-6. PubMed ID: 7741174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Zimmermann JJ; Lappas DG
    Anesth Analg; 1994 Oct; 79(4):670-4. PubMed ID: 7943773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli.
    Godavarti R; Davis M; Venkataraman G; Cooney C; Langer R; Sasisekharan R
    Biochem Biophys Res Commun; 1996 Aug; 225(3):751-8. PubMed ID: 8780685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparinase I from Flavobacterium heparinum. Mapping and characterization of the heparin binding domain.
    Sasisekharan R; Venkataraman G; Godavarti R; Ernst S; Cooney CL; Langer R
    J Biol Chem; 1996 Feb; 271(6):3124-31. PubMed ID: 8621711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of heparinase modified thrombelastography in liver transplantation.
    Harding SA; Mallett SV; Peachey TD; Cox DJ
    Br J Anaesth; 1997 Feb; 78(2):175-9. PubMed ID: 9068337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of heparinase in the field of medicine].
    Liu W; Jiang Y; Zhao L; Zhang P; Wang S
    Sheng Wu Gong Cheng Xue Bao; 2018 Dec; 34(12):1953-1962. PubMed ID: 30584706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparinase I from Flavobacterium heparinum. Identification of a critical histidine residue essential for catalysis as probed by chemical modification and site-directed mutagenesis.
    Godavarti R; Cooney CL; Langer R; Sasisekharan R
    Biochemistry; 1996 May; 35(21):6846-52. PubMed ID: 8639636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immobilized microbial heparinase for blood deheparinization.
    Linhardt RJ; Cooney CL; Tapper D; Zannetos CA; Larsen AK; Langer R
    Appl Biochem Biotechnol; 1984 Feb; 9(1):41-55. PubMed ID: 6476820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor of DNA polymerases alpha and delta in calf thymus DNA.
    Goulian M; Heard CJ
    Nucleic Acids Res; 1990 Aug; 18(16):4791-6. PubMed ID: 2118625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing miR-29 measurements in biobanked, heparinized samples.
    Warnement CM; Cismowski MJ; Rogers LK
    Life Sci; 2019 Dec; 238():116894. PubMed ID: 31626789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.